[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

G.L. Pharma GmbH - Strategic SWOT Analysis Review

September 2021 | 25 pages | ID: G023F64B676EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
G.L. Pharma GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

G.L. Pharma GmbH (G.L. Pharma) is a pharmaceutical company that provides a product mix of novel pharmaceutical drugs and branded generic drugs. The company’s core competence concentrates on therapeutic areas of cardiovascular, central nervous system, urology, cancer and opioid substitution therapy. It also has various products under development for treating vitamin B1 deficiency, opioid use disorder, severe pain, narcotic, epilepsy, overactive bladder, moderate pain, nausea, emesis and muscle spasms among others. G.L. Pharma distributes products to several markets across the world with its own marketing structures in Austria and Eastern Europe. The company has production sites in Lannach, Graz, and Vienna, Austria. G.L. Pharma is headquartered in Lannach, Austria.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

G.L. Pharma GmbH - Key Facts
G.L. Pharma GmbH - Key Employees
G.L. Pharma GmbH - Major Products and Services
G.L. Pharma GmbH - History
G.L. Pharma GmbH - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
G.L. Pharma GmbH - Business Description
G.L. Pharma GmbH - SWOT Analysis
SWOT Analysis - Overview
G.L. Pharma GmbH - Strengths
G.L. Pharma GmbH - Weaknesses
G.L. Pharma GmbH - Opportunities
G.L. Pharma GmbH - Threats
G.L. Pharma GmbH - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

G.L. Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
G.L. Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
G.L. Pharma GmbH, Recent Deals Summary

SECTION 4 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

G.L. Pharma GmbH, Key Facts
G.L. Pharma GmbH, Key Employees
G.L. Pharma GmbH, Major Products and Services
G.L. Pharma GmbH, History
G.L. Pharma GmbH, Other Locations
G.L. Pharma GmbH, Subsidiaries
G.L. Pharma GmbH, Key Competitors
G.L. Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
G.L. Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
G.L. Pharma GmbH, Recent Deals Summary

LIST OF FIGURES

G.L. Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
G.L. Pharma GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications